Skip to main content
Clinical Trials/NCT00260975
NCT00260975
Completed
Not Applicable

A Prospective, Longitudinal Investigation of the Neuropsychological and Psychosocial Effects of Cancer Therapy

Ottawa Hospital Research Institute0 sites112 target enrollmentJune 2001
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Ottawa Hospital Research Institute
Enrollment
112
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Many breast cancer patients treated with chemotherapy complain of problems with concentration and memory. This has been referred to as chemo fog. The current study is investigating this phenomenon by measuring mental function of breast cancer patients prior to and after exposure to chemotherapy, and by comparing mental function in those patients who receive chemotherapy and those who do not.

Detailed Description

Many breast cancer patients treated with chemotherapy complain of problems with concentration and memory. This has been referred to as chemo fog. The current study will investigate this phenomenon by measuring neuropsychological functioning in early stage breast cancer patients prior to and after exposure to chemotherapy, and by comparing change in cognitive function in patients who receive chemotherapy to similar breast cancer patients receiving hormonal therapy only.

Registry
clinicaltrials.gov
Start Date
June 2001
End Date
February 2008
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • stage I or II breast cancer; woman; 50-65 years old; post-menopausal

Exclusion Criteria

  • history of previous cancer or chemotherapy; significant neurological or psychiatric history

Outcomes

Primary Outcomes

Not specified

Similar Trials